EMERYVILLE, Calif., November 07, 2024--NovaBay® Pharmaceuticals, Inc. (NYSE American: NBY) reports financial results for the three and nine months ended September 30, 2024. EMERYVILLE ...

NovaBay Pharmaceuticals (NYSE:NBY) announced on Tuesday that it has received an unsolicited, non-binding offer from Refresh ...

NovaBay (NBY) announces that the Company has accepted a revised transaction proposal from PRN Physician Recommended Nutriceuticals, LLC to ...

View NovaBay Pharmaceuticals, Inc. (NBY) current and estimated P/E ratio data provided by Seeking Alpha.

NovaBay (NYSE:NBY) said it has accepted a revised offer from PRN Physician Recommended Nutriceuticals that increases the base purchase price of its Avenova eyecare business to $11.5M from $9.5M. In ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

NovaBay shares are trading higher after the company announced it reached a definitive agreement to sell its Avenova assets for $9.5 million to Physician Recommended Nutraceuticals. NovaBay ...